Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Englobal

Start price
Target price
Perf. (%)
€2.10
24.11.20
-
24.11.21
11.43%
02.06.21

Probably not worthwhile Investment
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€125.38
24.11.20
€130.00
0.94%
03.12.20

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
Las Vegas Sands Corp.

Start price
Target price
Perf. (%)
€48.89
24.11.20
-
24.11.21
-3.86%
08.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Higher risks for its business
buy
Aemetis Inc.

Start price
Target price
Perf. (%)
€1.74
23.11.20
€15.00
23.11.21
796.55%
24.11.21

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€118.90
23.11.20
€125.00
5.45%
24.11.20

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€163.80
23.11.20
€184.00
23.11.21
29.76%
02.06.21

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€85.27
23.11.20
€132.00
23.11.21
190.78%
24.11.21

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.76
23.11.20
-
23.11.21
157.64%
24.11.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
21.11.20
-
21.11.21
15.44%
22.01.21

Revenue growth >5% per year expected
EBIT decline/stagnation expected
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
21.11.20
-
21.11.21
28.49%
10.02.21

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€2.40
19.11.20
-
19.11.21
103.58%
20.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Dixie Group Inc.

Start price
Target price
Perf. (%)
€1.61
19.11.20
-
19.11.21
222.98%
20.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Vaalco Energy Inc.

Start price
Target price
Perf. (%)
€1.09
19.11.20
-
19.11.21
173.39%
20.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
DISH Network Corp. A

Start price
Target price
Perf. (%)
€28.40
18.11.20
-
18.11.21
-11.27%
27.01.21

Higher risks for its business
Very low/no dividend yield expected
Few uniques
buy
Tesla Inc

Start price
Target price
Perf. (%)
€135.75
18.11.20
€145.00
18.11.21
58.13%
20.09.21

Could be worthwhile Investment >10% per year
buy
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€2.80
18.11.20
€4.00
18.11.21
-25.00%
28.11.20

Could be worthwhile Investment >10% per year
Fair valuation
Bad rating
Few uniques